MarketScreener Editorial Features argenx SE
Equities
ARGX
NL0010832176
Biotechnology & Medical Research
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 774.80 EUR | -1.12% |
|
-0.84% | +29.13% |
| 12-04 | KBC Securities Upgrades Argenx to Buy, Boosts PT | MT |
| 12-02 | European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading | MT |
MarketScreener Editorial Features
Search
No results for this search
- Stock Market
- Equities
- ARGX Stock
- News argenx SE
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition




























